透明质酸
甲氨蝶呤
光热治疗
药物输送
阿霉素
化疗
靶向给药
癌症研究
纳米载体
化学
药品
谷胱甘肽
医学
药理学
纳米技术
内科学
材料科学
生物化学
免疫学
有机化学
酶
解剖
作者
Fei Yu,Maoshu Zhu,Nini Li,Mingtao Ao,Yang Li,Mengya Zhong,Yuan Qian,Huiyu Chen,Zhongxiong Fan,Yan Wang,Zhenqing Hou,Zhongquan Qi,Xiao Dong Chen,Xiao Dong Chen
标识
DOI:10.1016/j.cej.2019.122426
摘要
A combination of chemotherapy and photothermal therapy (PTT) against cancer, overcoming the intrinsic limitations of single-modal chemotherapy or PTT, has emerged as a promising strategy to achieve synergistic therapeutic effect. However, the lack of precise drug delivery and intelligent drug release based on photo-chemotherapy at specific tumor sites remained a challenge. Hence, the both tumor-specific targeting molecule (methotrexate) and ligand (hyaluronic acid)-introduced, glutathione-responsive amphiphiles (deoxycholic acid-hyaluronic acid-methotrexate, DA-SS-HA-MTX) were developed for synchronous delivery of indocyanine green (ICG) and doxorubicin (DOX). The as-synthesized DOX/[email protected] remarkably improved the intracellular drug uptake and accumulation owing to both the CD44/folate receptors-mediated synergistic targeting and the glutathione-triggered rapid drug release. Moreover, DOX/[email protected] efficiently accumulated at the tumor sites, realizing the notable tumor ablation under the guidance of dual-modal optical imaging. Taken together, this study provided a promising nanotheranostic agent for imaging-guided chemo-photothermal combination therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI